FDA Drug Application (090526) for OXYBUTYNIN by BARR LABS DIV TEVA

Back to FDA Applications sponsored by BARR LABS DIV TEVA

Application Number090526
Product Number001
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage3.9MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOXYBUTYNIN
Active IngredientOXYBUTYNIN



Back to FDA Applications sponsored by BARR LABS DIV TEVA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.